RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.
An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations ...
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...
The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
In the closing of the recent trading day, Moderna (MRNA) stood at $26.25, denoting a -1.83% move from the preceding trading day.
Canadian Business on MSN
Why a Homegrown Biotech Sector Matters for Canada
Canada has the talent and innovation to lead in biotech, but without stronger investment, breakthroughs risk leaving our ...
Stocks rose to begin a busy week that will see a flurry of corporate earnings reports, with investors also awaiting further ...
The space and telecom industries can look increasingly intertwined as satellite roaming—today for messages, tomorrow for data ...
Many of the signs of perimenopause can also be symptoms of other conditions, and some of these get increasingly dangerous if ...
Immunology's transformative impact on global health, from Nobel Prizes to COVID-19 vaccines, underscores its critical role in ...
BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “Company”), today announced that it has entered into a non-binding (“Birch”), a Canadian biopharmaceutical company developing regenerative ...
BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results